| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Former Director | EVP, R&D &Chief Scientific Of +1 more
3 companies
Haqq Christopher serves as an EVP, R&D &Chief Scientific Of at ATRA and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 0 buys and 50 sells. Those positions are worth an estimated $10.8M at current prices.
The biggest single holding is ATRA (~$10.8M) as EVP, R&D &Chief Scientific Of. The recent filings there lean toward selling, a net 243,103 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2015 | ATRA Atara Biotherapeutics, Inc. | Chief Medical Officer | Sell | 2,500 | $62.94 | $157,353.00 | -1.0% | |
| Jul 1, 2015 | ATRA Atara Biotherapeutics, Inc. | Chief Medical Officer | Sell | 2,500 | $51.68 | $129,196.00 | -1.0% | |
| Jun 15, 2015 | ATRA Atara Biotherapeutics, Inc. | Chief Medical Officer | Sell | 7,500 | $46.42 | $348,116.00 | -2.9% | |
| Jun 1, 2015 | ATRA Atara Biotherapeutics, Inc. | Chief Medical Officer | Sell | 2,500 | $41.47 | $103,664.50 | -0.9% |